Neurobiologic, Immunologic, and Rheumatologic Markers in Youth With PANS

Summary

This study is an investigation of the neurologic, immunologic, and rheumatologic markers of Pediatric Acute-Onset Neuropsychiatric Syndrome (PANS). PANS is a condition characterized by the abrupt, dramatic onset of obsessive compulsive disorder (OCD) and/or eating restriction accompanied by equally abrupt and severe co-morbid neuropsychiatric symptoms, which include anxiety, emotional lability, depression, irritability, aggression, oppositionality, deterioration in school performance, behavioral (developmental) regression, sensory amplification, movement abnormalities, sleep disturbance, and…

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

• Pediatric Acute-Onset Neuropsychiatric Syndrome
• Pediatric Autoimmune Neuropsychiatric Disorders Associated With Streptococcal Infections
• PANS
• PANDAS

Eligibility basics and study details

Study type

Observational

Phase

Not applicable

Ages

4 to 18 years

Sex

All

Healthy volunteers

Accepted

Sponsor

Stanford University

Last updated on ClinicalTrials.gov

October 6, 2016

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites